Evaluation of cell-penetrating peptide delivery of antisense oligonucleotides for therapeutic efficacy in spinal muscular atrophy
Antisense oligonucleotides (ASOs) are a widely used form of gene therapy, which is translatable to multiple disorders. A major obstacle for ASO efficacy is its bioavailability for in vivo and in vitro studies. To overcome this challenge we use cell-penetrating peptides (CPPs) for systemic delivery o...
Main Authors: | Hammond, S, Abendroth, F, Gait, M, Wood, M |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Springer
2019
|
Similar Items
-
Identification of a Peptide for Systemic Brain Delivery of a Morpholino Oligonucleotide in Mouse Models of Spinal Muscular Atrophy
by: Shabanpoor, F, et al.
Published: (2017) -
Spinal muscular atrophy: antisense oligonucleotide therapy opens the door to an integrated therapeutic landscape
by: Wood, M, et al.
Published: (2017) -
NOVEL CELL PENETRATING PEPTIDES FOR SKELETAL AND CARDIAC MUSCLE DELIVERY OF PMO ANTISENSE OLIGONUCLEOTIDES FOR THE TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY
by: Hammond, S, et al.
Published: (2011) -
Antibody-oligonucleotide conjugate achieves CNS delivery in animal models for spinal muscular atrophy
by: Suzan M. Hammond, et al.
Published: (2022-12-01) -
Systemic peptide-mediated oligonucleotide therapy improves long-term survival in spinal muscular atrophy
by: Hammond, S, et al.
Published: (2016)